Zero dead leg valve

The zero dead leg valve system addresses mixing and sampling inefficiencies in bioreactors by ensuring homogeneous fluid distribution and accurate sampling, enhancing bioreactor performance and reducing waste.

JP2024156833AInactive Publication Date: 2024-11-06EMD MILLIPORE CORP
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2024125699
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-21
Filing Date
2024-08-01
Publication Date
2024-11-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing bioreactor systems face inefficiencies in mixing and sampling biological fluids due to dead legs, leading to inconsistent concentrations and waste of valuable reagents, particularly in large capacity containers, and traditional mixing methods can damage cells or require inefficient sterilization processes.

Method used

A valve system with a zero dead leg design, featuring a fluid transfer device with a movable plunger and expansion flange, ensuring homogeneous mixing and sampling by eliminating stagnant areas within the container.

Benefits of technology

The valve system enhances mixing efficiency and sampling accuracy by maintaining consistent concentrations and reducing reagent waste, while being compatible with sterilization processes, thus optimizing bioreactor performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156833000001_ABST
    Figure 2024156833000001_ABST
Patent Text Reader

Abstract

To provide containers useful as mixers or bioreactors.SOLUTION: The invention includes a valve 12 having: a body 14 having an elongate bore 20 formed through at least a portion of the interior thereof; and a generally hollow movable plunger 62 contained in the bore. The bore is a lateral central bore formed through an interior length of the body. The body is formed from two sections, namely, a rotating first section 26 and a stationary second section 28. The first section rotates partially around a portion of the second section and plunger. A bore section 34 cooperates with an inner wall of the first section, and a bore section 36 corresponds to an inner wall of the second section. The valve is operated when the first section of the body is rotated, engaging the second section of the body and the plunger, driving the plunger within the bore, thereby operating the valve.SELECTED DRAWING: Figure 1C
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application claims the benefit of priority to U.S. Provisional Patent No. 62 / 864,648, filed June 21, 2019, which is incorporated by reference in its entirety.

[0002] SUMMARY OF THE DISCLOSURE Embodiments of the present disclosure relate to a container useful as a mixer or bioreactor. More particularly, embodiments disclosed herein include a valve in fluid communication with an interior volume of the container. [Background technology]

[0003] Traditionally, biological fluids have been processed in systems that use stainless steel containers. These containers are sterilized after use so that they can be reused. The sterilization procedures are expensive, laborious, and often ineffective. More recently, the containers have been equipped with flexible containers, such as flexible containers made from flexible polymeric films. To provide greater flexibility in production and to reduce the time required for sterilization and regeneration of equipment, manufacturers use disposable sterile containers, such as bags, for example two-dimensional (pillow-shaped) or three-dimensional bags. Such bags are used once to process biological products, whether in batch, semi-continuous, or continuous mode, and are then discarded. These disposable bags consist of a system for mixing two or more components, at least one of which is liquid and the rest liquid or solid, the bag having a mixing element or the like for mixing the contents as homogeneously as possible.

[0004] It is often advantageous to feed materials and / or processing aids, such as antifoam agents, nutrients, etc., into a system for cell growth in a bioreactor or for other purposes in a bag or mixer during processing. Typically, these materials are added through multiple ports at the top and bottom of a container or bag, and a mixing element distributes them. However, this is an inefficient method for distribution in that the ports are typically located along the inside surface of the container, often resulting in incomplete distribution of materials to where they are needed. For example, a port may be located at the bottom or side wall of a container and have a tube attached to it. The tube may become filled with a fluid having a different concentration, i.e., thinner or thicker components, than that of the fluid remaining in the container, thereby reducing the accuracy of product samples taken and potentially misleading. Similarly, if aids and agents settle, whether introduced into the container from the top, bottom, or side wall, before dissolution, near the port, or in the tube (i.e., in a "dead leg"), they are not available for subsequent mixing in the fluid, wasting valuable reagents. Traditionally, such waste was only avoided by introducing reagents very slowly into the container, or by using very fast but undesirable mixing speeds that impart shear stress. Also, samples are often taken from ports or tubing that have dead legs that are often of different concentrations, and / or require the removal of significant amounts of biological fluid, which is wasteful. Manufacturers can take samples from containers using dip tubes, but they must be sterile and can contaminate the fluid in the container. Therefore, the use of dip tubes is not preferred.

[0005] Good mixing of drugs, auxiliaries and ingredients helps optimize bioreactor processes. The production of vaccines, liquids and biological components often requires the addition of soluble solid processing agents. For example, aluminum salts are used as adjuvants to improve the effectiveness of vaccines by enhancing the body's immune response. Unfortunately, adjuvants often consist of particle sizes larger than 0.2 microns and tend to settle to the bottom of the container and not subsequently dissolved or mixed into solution.

[0006] A well-designed mixing system serves three basic functions: production of constant conditions (nutrients, pH, temperature, etc.) in homogeneous distribution, dispersion of gases, e.g., to supply oxygen and extract carbon dioxide where and when needed within the bioreactor or container, and / or optimization of heat transfer. Providing acceptable mixing without damaging shear effects becomes more difficult as the size and / or aspect ratio of the bioreactor container increases. Certain commercially available mixers and bioreactor platforms include a single bottom-mounted impeller. A single bottom impeller creates a vortex with stagnation zones, reducing mixing. Multiple impellers and / or faster impeller speeds improve overall mixing and mixing rates. However, the higher shear rates associated with multiple impellers and / or faster impeller speeds, as well as several baffles, can damage the cells within the container. Summary of the Invention [Problem to be solved by the invention]

[0007] Some bags, bioreactors, or containers, whether rigid or flexible, include baffles formed vertically along at least a portion of the inner sidewall of the bag to improve mixing. These baffles are typically sleeves and often have rigid members such as wood, plastic, or metal shaped to fit inside the sleeve, potentially damaging the container. Large volume bags, e.g., bags, containers, or bioreactors with 1000L to 3000L capacity, present a challenge to mix components uniformly, especially as the height of these systems increases, even though the aspect ratio of height to width decreases, resulting in reduced mixing efficiency. [Means for solving the problem]

[0008] It would be an advancement in the art to provide a valve for use with a container for mixing biological fluids that promotes homogenous mixing and sampling. It would also be an advancement in the art to provide a disposable valve with a container for mixing biological fluids that promotes homogenous mixing and sampling. It would be a further advancement to provide a valve with zero dead legs in the process so that the concentration of components, drugs, auxiliary agents, etc. within the solution or fluid is consistent.

[0009] A fluid transfer device, such as a valve, includes a body having a first section and a second section, an extension flange attached to or disposed as an integral part of the second section of the body, an elongated passage or bore extending through the body and having a proximal end and a distal end, a longitudinally displaceable plunger disposed within and extending along the bore, the plunger having a proximal end and a distal end, the plunger having a first position displaced toward the distal end of the bore and a second position displaced toward the proximal end of the bore, and a diaphragm seal attached to the proximal end of the plunger and sealing the bore at its proximal end. a gland seal sealing the bore at a location intermediate the diaphragm seal and a distal end of the bore, and a fluid transfer opening in the bore between the diaphragm seal and the gland seal, a plunger passing through and sealingly secured to the gland seal, longitudinal displacement of the plunger moves the diaphragm seal to open the bore, the gland seal responds to displacement of the plunger and elongates to maintain a seal around the plunger, a fluid flow path is established between the open proximal end of the bore and the fluid transfer opening, and longitudinal displacement of the plunger towards its first position moves the diaphragm to open the bore. The fluid transfer device or valve optionally further comprises an extended flange having a surface that is substantially coplanar with a surface at the second position when the plunger is displaced towards the proximal end of the passage or bore, creating a zero dead leg condition as substantially shown and / or described in connection with at least one of the drawings, as set forth in the claims. Various advantages, aspects, novel and inventive features of the present disclosure, as well as details of illustrative embodiments thereof, will become more fully understood from the following description and drawings.

[0010] An embodiment of the present disclosure includes a valve in fluid communication with a container, such as a bag, bioreactor, for a fluid, comprising an interior volume formed of a flexible material, optionally one or more inlets in said container, optionally one or more outlets in said container, an impeller assembly at least partially mounted within said volume of said container, and a baffle within said interior volume of said container. In some embodiments, an extension flange may be attached to the valve and the bag or bioreactor. In some embodiments, the extension flange may be attached to the valve via a clamp. In some embodiments, the valve may have an integrally formed extension flange for attachment to the bag or bioreactor. The flange is attached to the bag, bioreactor or container, for example, using an adhesive or by heat sealing. The bag or bioreactor may be a two-dimensional bag or a three-dimensional bag, as known to those skilled in the art.

[0011] Embodiments according to the present disclosure also include a method for processing and / or sampling a biological fluid. The biological fluid(s) can be delivered or otherwise provided into a bag or bioreactor having an internal volume. A fluid transfer device, such as a valve, is disposed downstream and in fluid communication with the bag or bioreactor. A flange may comprise a relatively large surface for attachment to the bag or bioreactor. The valve is attached to the bag or bioreactor along an extended area of ​​the flange that is attached to the valve or is an integral part of the valve. The biological fluid is mixed, for example, using an impeller and / or mixing blades. The impeller may be attached to a physical shaft as a drive mechanism or may be powered by a magnetically driven pump using a balanced magnetic field to generate rotation of the impeller. To mix with the biological fluid, solid processing agent(s) may be delivered to the internal volume of the bag or bioreactor. The valve may also comprise a plunger to provide a liquid-tight seal when in a closed position and to allow delivery of fluid when in an open position. In some embodiments, the flange comprises an upper surface that is substantially flush with a surface of the plunger during the closed position. In some embodiments, the surface of the plunger is higher than the top surface of the flange. Because the flange is attached to the bag or bioreactor, mixing occurs without dead-leg areas, greatly improving mixing efficiency. Furthermore, sampling during processing of the fluid is also more representative of the concentrations of cell cultures, viruses, various drugs and / or auxiliary agents.

[0012] The embodiments of the valve(s) having an extended flange according to the present disclosure described herein facilitate mixing of various processing agents or auxiliary substances, such as adjuvants, cell culture media, nutritional additives, antifoam agents, and the like. [Brief description of the drawings]

[0013] [Figure 1A] FIG. 1 illustrates a cross-sectional view of one embodiment of a valve according to the present disclosure in a closed position. [Figure 1B] FIG. 1 illustrates a cross-sectional view of one embodiment of a valve according to the present disclosure in a closed position. [Figure 1C] FIG. 1C is a cross-sectional view of an embodiment of the valve of FIGS. 1A and 1B with the plunger in an open position. [Figure 2A] FIG. 13 is an exploded perspective view of an embodiment according to the present disclosure further including alternative embodiments of upstream and downstream mounting components. [Figure 2B] FIG. 13 is an exploded perspective view of an embodiment according to the present disclosure further including alternative embodiments of upstream and downstream mounting components. [Diagram 3] FIG. 1 is a perspective view of a valve having an extended flange according to an embodiment of the present disclosure. [Figure 4A] FIG. 13 is a perspective view of an embodiment further comprising a removable extension flange and clamp in accordance with an embodiment of the present disclosure. [Figure 4B] FIG. 13 is a perspective view of an embodiment further comprising a removable extension flange and clamp in accordance with an embodiment of the present disclosure. [Figure 4C] FIG. 4C is a front view of the embodiment of FIGS. 4A and 4B, showing the extension flange, valve, and clamp in an assembled state. [Diagram 5] FIG. 4D is a cross-sectional front view of FIG. 4C of a valve having an extended flange attached to a bag or biocontainer according to an embodiment of the present disclosure. [Figure 6] FIG. 6 is a cross-sectional front view of FIG. 5 of a valve with an extended flange attached to a bag or biocontainer, further showing solid processing aids, according to an embodiment of the present disclosure. [Figure 7] FIG. 13 is a perspective view of a second embodiment of a valve for use with a two-dimensional bag, in accordance with an embodiment of the present disclosure. [Figure 8] FIG. 13 is a perspective view of a third embodiment of a valve for use with a two-dimensional bag, in accordance with an embodiment of the present disclosure. [Figure 9] 4D illustrates the extension flange, valve, and clamp in an assembled state as shown in FIG. 4C, further comprising a drain plate in an exploded view according to an embodiment of the present disclosure. [Figure 10] 1 is a prior art system including a bag with a port, a tube clamp, and a dead-leg tube area. [Figure 11] 13 is a perspective view of an additional embodiment of a locking tool for use with a valve and bag according to an embodiment of the present disclosure. [Figure 12] FIG. 13 is a front view of a valve for use with a bag according to some embodiments of the present disclosure. [Figure 13] 13 is a perspective view of the valve of FIG. 12 disposed within the locking tool of FIG. 11 for a fluid transfer system according to an embodiment of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] Thus, in a manner that allows a detailed understanding of the features disclosed herein, a more particular description of the embodiments of the present disclosure briefly summarized above can be obtained by referring to the attached drawings. It should be noted, however, that the attached drawings show only typical embodiments of the present disclosure and therefore should not be considered as limiting its scope, since the described and illustrated embodiments may admit of other equally effective embodiments. It should also be understood that elements and features of one embodiment may be found in other embodiments without further recitation, and the same reference numerals may be used to indicate equivalent elements common to the figures.

[0015] The term "dead leg" within this disclosure is defined as a region within a conduit, tube, or channel that typically leads to an outlet that sees less fluid flow or turbidity than within the larger volume of the container in fluid communication with it, but the dead leg region is not necessarily isolated from the flow.

[0016] The term "valve" within this disclosure is generally defined as a mechanical or electrical, or electromechanical device that can control the passage, i.e., flow, of a fluid through a channel or bore through the device.

[0017] The terms "bioreactor," "bag," and "container" are generally used interchangeably within this disclosure. A flexible bioreactor, bag, or container refers to a flexible vessel that can be folded, crushed, expanded, etc., and can contain, for example, a biological fluid. A disposable bioreactor, bag, or container is a vessel that is typically flexible and is used once and discarded.

[0018] The term "sterility" is defined as being free of contaminants, particularly within the bioprocessing industry, and free of viruses, bacteria, pathogens, and other microorganisms.

[0019] The term "adjuvant" within this disclosure is defined as a substance that enhances the body's immune response to, for example, an antigen.

[0020] The term "upstream" is defined as being located in front of another component relative to the direction of fluid flow.

[0021] In general, embodiments according to the present disclosure describe a sterile fluid transfer device, such as a flow-through connector or valve for transporting fluids, e.g., fluids, solutions, liquids, and / or gases. In some embodiments, the fluid transfer device has a body, a bore disposed in an interior region of the body, and a moveable (linearly, e.g., a push / pull operation, and / or rotationally, e.g., a torque applied to the body to open and close the bore) plunger housed within the bore. The body is formed from first and second sections. The first section has a first end including a first opening and a terminal attachment component, such as a flange, surrounding the first opening for attaching the body to an upstream component(s). The second section has a second end including a second opening, and a bore connects the first opening and the second opening. The first section can optionally rotate relative to a portion of the second section. In some embodiments, the first section and a portion of the second section extend and retract in a push-pull manner.

[0022] The movable plunger includes a first end including a first opening, a second end including a second opening, and a fluid channel disposed inside the plunger connecting the first and second openings of the plunger. In some embodiments, the movable plunger rotates and moves linearly or axially. In some embodiments, the plunger includes components for facilitating and simultaneously preventing its linear or axial movement within the bore during rotation of the first section of the body when the device is operated (i.e., opened / closed). In some embodiments, the plunger includes components for facilitating and simultaneously preventing its linear or axial movement within the bore during engagement of the first section of the body when the device is operated or manipulated (i.e., opened / closed).

[0023] The fluid transfer device, i.e., valve, is in a closed position when the first end of the plunger is aligned, for example, with a mounting component surrounding the first opening of the body, where a fluid-resistant seal is formed. In some embodiments, the surface of the plunger is higher than the top surface of the flange. A steam-compatible surface for sterilization purposes is also formed, and the flange is made of a steam-compatible plastic, for example, polypropylene, acetal, nylon, etc. The device is in an open position when the first end of the plunger is not aligned with a mounting component surrounding the first opening of the body, whereby fluid can flow into the device from an upstream component, for example, a bag, bioreactor, or biocontainer.

[0024] Turning to the figures, Figures 1A and 1B are cross-sectional views of an embodiment according to the present disclosure in a closed position. Several embodiments of the present disclosure are shown in Figures 1A, 1B, and 1C, which include a fluid transfer device, e.g., a valve 12 having a body 14 with an elongated bore 20 formed through at least a portion of the interior of the body 14, and a generally hollow movable plunger 62, i.e., a longitudinally displaced plunger, housed within the bore 20. The bore 20 is a transverse central bore formed through the interior length of the body 14, as shown in Figure 1C. The body 14 is formed from two sections, a rotating first section 26 and a stationary second section 28, as shown. The first section 26 rotates partially around a portion of the stationary second section 28 and the plunger 62. The bore section 34 generally cooperates with the inner wall of the rotating first section 26, and the bore section 36 generally corresponds to the inner wall of the stationary second section 28. 1C, each of the bore sections (34, 36) have a different diameter. As described in more detail herein, the valve 12 is operated (i.e., opened and closed) when the first section 26 of the body 14 is rotated to engage the stationary second section 28 of the body 14 with the plunger 62 and drive the plunger 62 linearly (e.g., axially) within the bore 20, thereby operating (i.e., opening and closing) the valve 12.

[0025] FIG. 1C is a cross-sectional view of an embodiment of the valve 12 of FIGS. 1A and 1B with a plunger in an open position. As shown in FIG. 1C, the first section 26 of the body 14 is generally hollow and has an opening 18 at one end for receiving a plunger 62. The first section 26 includes a protruding lip or edge component 38 that is rotatably engaged by a stationary wall receiving groove 44 of the outer stationary wall section 28. The stationary second section 28 of the body 14 is generally hollow and has an opening 16 at one end that allows fluid provided from an upstream source (not shown) to pass therethrough during the open position. The opening 16 also receives a bottom 63 of the plunger when the valve 12 is closed. The stationary section 28 includes an outer wall component 42 for rotatably engaging an inner wall section 40 of the rotating section 26. As shown in FIG. 1C, the inner wall of the second section 28 forms a stationary bore section 36 having four sections. 1C shows a first stationary bore diameter 36a, a first transition stationary bore section 36b, a second stationary bore diameter 36c, and a second transition stationary bore section 36d. The first bore diameter 36a is smaller than the second bore diameter 36c. The second bore diameter 36c is a set diameter. The first transition bore section 36b is disposed between the first and second bore diameters (36a, 36c) and has an outwardly tapered diameter along its length. The diameter of the first transition section 36b is, in some embodiments, a linear outward progression between the first and second bore diameters (36a, 36c). The diameter of the first transition section 36b adjacent to the first diameter 36a is equal to the diameter 36a, and the diameter of the first transition section 36b adjacent to the second diameter 36b is equal to the diameter 36b.

[0026] As shown in FIG. 1C, the plunger 62 has three general regions comprising a first, second and third region. The diameter of the first region 24 is equal to or less than the first bore set diameter 34a. The diameter of the second region 25 is equal to or less than the second static bore diameter 36c. The diameter of the third region 29 is equal to or less than the diameter of the first static bore diameter section 36a. The plunger 62 has a bottom component 63 at the end of the third region 29 for blocking the opening 16 of the static section 28 when the device is in the closed position as shown in FIG. 1A. Some embodiments of the present disclosure include a static diaphragm seal 60, as shown in FIG. 1C, disposed at the bottom 63 of the plunger 62 and forming a liquid-tight, fluid-resistant seal between an outer wall 61 of the bottom end 63 of the plunger and an inner wall 82 of the body static section 28 that defines the opening 16.

[0027] The plunger 62 also includes two openings, a first opening 64 and a second opening 66. A channel 68 is disposed inside the plunger and connects the first and second openings (64, 66), thereby forming a fluid path to a downstream component. As shown in FIG. 1C, the first opening 64 is located in the first portion 24 of the plunger and the second opening 66 is located in the second portion 25 of the plunger. In other embodiments, the plunger 62 can include additional openings and internal fluid paths. In some exemplary embodiments, the plunger 62 includes at least an opening in the second portion 25 (not shown).

[0028] As shown in Figures 1A-1C, some embodiments of the present disclosure include the plunger 62 comprising components for preventing rotation of the plunger 62 within the bore 20 while facilitating linear motion of the plunger 62 when the valve 12 is operated (i.e., opened and closed). As shown in Figure 1A, some embodiments for achieving linear motion of the plunger 62 show a plunger having a pair of wings (74, 76), fins, or the like, extending from an outer wall of the plunger 62 toward an inner wall of the second section 28 of the body 14. The second section 28 has components for interacting with the pair of wings (74, 76) comprising two corresponding pairs of parallel slots (70, 72), grooves, or the like, disposed in an inner wall of the section 28 for receiving the pair of wings (74, 76) to limit rotation of the plunger 62 and facilitate linear motion of the plunger 62 within the bore 20. A pair of wings (74, 76) ride between each corresponding pair of slots (70, 72) to facilitate linear movement of plunger 62 within bore 20 during operation (opening and closing) of valve 12.

[0029] In Figure 1C, when the valve 12 is in the closed position, the bottom end 63 of the plunger 62 aligns with the first flange 80 to form a surface 90. The valve 12 with surface 90 is a vapor-compatible surface that provides a sterile barrier to the environment for the interior of the device 12, the plunger 62, and any downstream components therefrom. In the closed position, as in Figure 1A, the bottom end (not shown) of the plunger 62 does not allow fluid from an upstream component (not shown) to enter the valve opening 16 (shown in Figure 1C), thereby preventing fluid from traveling downstream.

[0030] In FIG. 1C, the first section 26 also includes an inner wall having a stationary wall engagement section 40, forming a bore section 34 having four sections. There is a first bore set diameter 34a, a transition bore section 34b, a second bore diameter 34c, and a third bore diameter 34d. The first set diameter 34a engages the plunger as it moves linearly within the bore 20. The transition section 34b is disposed between the first and second diameters (34a, 34c) and has an outwardly tapered diameter along its length. The diameter of the transition section 34b is preferably a linear outward progression from the first diameter section 34a, such that the diameter of the transition section 34b adjacent the first diameter 34a is equal to the first diameter 34a, and the diameter of the transition section 34b adjacent the second diameter 34c is equal to the diameter 34c. In some embodiments, third diameter 34d is preferably less than diameter 34c, and in some embodiments, greater than diameter 34a.

[0031] 2A and 2B further illustrate alternative embodiments of the upstream and downstream mounting components. 2A is an exploded perspective view of an embodiment according to the present disclosure, including a plunger section 24 having a barbed end 92 for connecting the device to a downstream component, in this example, tubing 72. As shown in FIG. 2B, the end of the first plunger section 24 includes a terminating flange 78 for connecting the device 12 to a downstream component, such as terminating flange 94. By way of example and not limitation, the downstream component attached to the device by the terminating connection feature of the plunger 62 can include, for example, a plastic tubing 72 attached to a plastic bag, container or bioreactor or other type of known receptacle (not shown), as shown in FIG. 2A. As shown in FIGS. 2A and 2B, the valve 12 has a component at one end of the stationary section 28 of the body for attaching the device to an upstream component. In this embodiment, the first flange 80 is attached to a second flange 89 of the upstream component 88.

[0032] By way of example, the upstream component attached to the apparatus can be a pipe with a mounting flange (as shown in Figures 2A and 2B), a stainless steel or disposable plastic tank with an outlet, or any other attachment mode commonly known in the art for connecting a component to a transfer apparatus. For example, flange 80 of valve 12 can be connected to a second flange 89 or pipe of upstream component 88 by a clamp such as a Tri-Clover™ fitting / clamp (shown below), a Ladish™ fitting, a ClickClamp™ clamp, or the like.

[0033] When the valve 12 is used to fill a downstream component, such as a bag or any collection container attached to tubing 72, the device is opened by rotating the rotating section 26 of the body, which moves the plunger 62 (see FIG. 1B) linearly away from face 90, allowing fluid to flow into the opening 16 (see FIG. 1C) and ultimately out through the tubing 72 and out the opening outlet 64 to a bag, any collection container, or other fluid transfer device (not shown). Once the bag or bioreactor is full, the rotating section 26 is rotated in the opposite direction to move the plunger linearly again, this time in the opposite direction, to seal the opening 16 closed to fluid from the upstream component.

[0034] One or more seals are disposed along the length and ends of the plunger 62 to form a fluid-tight seal between various portions of the plunger 62 and the bore 20 when the device is in a closed or open position. As shown in FIG. 1A, the seals 60 and 54 are partially received within the grooves 46 and 48. As shown in FIGS. 1A-1C, the seals may be mounted on the plunger 62. However, different configurations of seals and their arrangements may be used as desired. For example, FIG. 1A shows the seals 46 and 60 formed in grooves in the plunger 62. A linear or gland seal 51 is held within a groove 50 on the inner wall of the stationary bore section and within the groove 46 of the plunger 62. Other embodiments of the present disclosure are also contemplated, such as molding the valve 12 into disposable plastic containers, such as disposable process bags for the manufacture and transfer of biotechnical products and the like. Such bags are available, for example, from EMD Millipore Corporation (Burlington, Massachusetts, USA).

[0035] 3 is a perspective view of a valve 12 having an extended flange 110 according to an embodiment of the present disclosure. The extended flange 110 has a process side 110a and a non-process side 110b opposite the process side 110a. The extended flange 110 is attached to a bag or biocontainer (not shown) by heat sealing, ultrasonic heating, chemical adhesives, or the like. In some embodiments, the non-process side 110b of the extended flange 110 is attached to the bag or biocontainer. The valve 12 comprises a first section 26 and a second section 28. The first section 26 rotates partially around a portion of the second section 28 and the plunger 62. Optionally, the second section 28 further comprises one or more flats 114. A wrench can engage the flat(s) 114 to prevent the second section 28 from moving during opening and closing of the valve. By limiting the travel of the second station 28, the bag bonded thereto is not subjected to stress, tearing, etc., when the first section 26 is rotated on top opening and closing the valve 12. The plunger 62 may receive one or more cams 56 (shown) that ride in one or more cam slots 58 (shown) located in the rotating section 26 of the body 14. The arrangement of the cams 56 and slots 58 acts to limit the length that the plunger 62 moves linearly within the bore (not shown) when the device is actuated (opened or closed). When the valve 12 is in the closed position, the cams 56 are in the closed position of the cam slots 58, as shown in FIG. 3. When the valve 12 is in the open position (not shown), the cams 56 are in the open position of the cam slots 58. The extension flange 110 may be integrally formed with the second section 28, i.e., permanently bonded together or formed together in an injection molding operation such that they cannot be separated without destruction.

[0036] 4A and 4B are perspective views of an embodiment of the present disclosure including a valve 612 and further including a removable extension flange 210 and a clamp 150 according to an embodiment of the present disclosure. The valve 612 includes a second section 28a and a concave flange 80a in which an O-ring 91 can be seated. As shown in FIG. 4B, the extension flange 210 defines a central bore 132 and is disposed adjacent to the cylinder 130 and a shoulder 140 having a larger diameter than the cylinder 130. The outer diameter of the shoulder 140 is generally similar to the outer diameter of the concave flange 80a. A tri-clamp 150 with a fastener 170 is shown, although many clamps are suitable. When assembled, the extension flange 210 mates with the valve 612 and the surface of the shoulder 140 distal to the cylinder 130 contacts the concave flange 80a. Typically, an O-ring 91 or other suitable sealing means is disposed between the shoulder 140 and the concave flange 80a. It should be further appreciated that the cylinder 130 may also be of sufficient length to incorporate one or more flats (as discussed above with respect to FIG. 3).

[0037] FIG. 4C is a front view of the embodiment of FIGS. 4A and 4B, showing the extension flange 210, valve, and clamp 150 in an assembled state. As described above, once the shoulder 140 and the recessed flange 80a are mated, the tri-clamp 150 is placed around both. The fastener 170 can then be tightened to form a liquid-tight seal. In practice, the extension flange 210 may first be glued to a bag or container (as shown below) and then assembled to the recessed flange 80a with the clamp 150. The valve 612 is then in communication with the bag or container. Once the valve 612 is connected, it can be operated. As shown, the valve 612 is in a closed position. To open the valve 612, a user can grasp the clamp 150 and the first section 26 of the body 14 with one hand. By rotating the body 14 while keeping the clamp 150 non-rotating, the user can open the valve 612 without compromising the seal between the bag and the extension flange 210.

[0038] 5 is a cross-sectional front view of the valve 612 of FIG. 4C having an extended flange 210 bonded to a bag or biocontainer 100 according to an embodiment of the present disclosure. The valve 612 operates similarly to the valve 12 described above (and valves 112, 212 described below). The valve 612 is bonded to the bag 100. The bag 100 has an inner surface 104 and an outer surface 102. The extended flange 210 is bonded to the bag 100 on the inner surface 104. The plunger 62 also has at least two openings, a first opening 64 and a second opening 66. A channel 68 is disposed in the interior of the plunger and connects the first opening 64 and the second opening 66, thereby forming a fluid pathway to a downstream component. The first opening 64 is disposed in the first portion 24 of the plunger, and the second opening 66 is disposed in the second portion 25 of the plunger. In some embodiments, the plunger 62 can include additional openings and internal fluid pathways. As shown, when the valve 612 is in the closed position, the bottom end 63 of the plunger is aligned with the flange 210 to form surface 90, providing the valve with a steam-compatible surface and a sterile barrier to the environment for the interior of the valve, plunger, and any downstream components. Note that surface 90, the extended flange 210, and the inner surface 104 of the bag 100 are substantially coplanar, so no dead-leg condition is created. In some embodiments, the surface of the plunger is higher than the top surface of the flange while in the closed position, and a seal is maintained by an O-ring. As shown, the plunger 62 is attached to the tubing 202 downstream of the bag 100.

[0039] FIG. 6 is a cross-sectional view of the valve 612 of FIG. 5 with the extended flange 210 attached to the bag or biocontainer 100 according to an embodiment of the present disclosure, further showing the solid processing aid 99. As shown, the processing aid 99 is inside the bag 100. The valve 612 is closed, and all of the processing aid 99 is obviously available for dissolution. Thus, there are no dead-leg regions. In other words, all of the processing aid 99 is equally located within the bag 100. Also, there are no regions within the bag 100 that are expected to have any different physical properties (such as concentration differences within the liquid solution within the bag 100). The system (bag 100) and valves (12, 112, 212, 612) described herein can further be referred to as having a "negative" dead-leg. Because face 90 of plunger 62, when in the closed position, actually projects or protrudes above inner surface 104 of bag 100 and / or extended flanges 80a, 80b, 80c, 110, 210, etc., there can be no dead legs for processing aids or stagnant areas forming within bag 100.

[0040] FIG. 7 is a perspective view of a second embodiment of a valve 112 for use with a two-dimensional bag (not shown) according to the present disclosure. The valve 112 comprises a first opening 64 adjacent to the plunger 62. The plunger 62 comprises a barbed end 92 for connecting the valve to a downstream component at a first end. The valve 112 further comprises a first flange 80b having an attachment region 122. The attachment region 122 can be attached to a 2D bag, bioreactor, or container (not shown). The attachment region 122 may be attached to the bag via, for example, adhesive and / or heat sealing. The face 90 of the plunger 62 (while in the closed position) also extends into the closed volume of the 2D bag (not shown). When the valve 112 is used to fill a downstream component such as a collection vessel, the valve 112 is opened by rotating the first section 26, which moves the plunger 62 linearly away from the face 90, allowing fluid to enter the opening and eventually flow out of the opening 64. Once the bag or bioreactor is full, the first section 26 rotates in the opposite direction to move the plunger linearly again, this time in the opposite direction, to seal the opening closed to fluid from the upstream components. In practice, when the attachment region 122 is bonded to the bag, the second section 28 is held stationary and the first section 26 is rotated, so as not to compress the bond between the attachment region 122 and the bag or bioreactor 100. As mentioned above, flats may be placed or molded into the second section 28 to facilitate gripping.

[0041] 8 is a perspective view of a third embodiment of a valve 212 for use with a two-dimensional bag, according to an embodiment of the present disclosure. The valve 212 includes a first opening 64 adjacent to a plunger 62. The plunger 62 includes a barbed end 92 for connecting the valve 212 to a downstream component at the first end. The valve 212 further includes a first flange 80c that can be attached to a bag, bioreactor, or container (not shown). A flat may be disposed or molded into the second section 28, as described above.

[0042] 9 illustrates an exploded view of the extension flange 210, valve 612, and clamp 150 in an assembled state as shown in FIG. 4C according to an embodiment of the present disclosure, further comprising a drain plate 190. The drain plate 190 comprises a first planar surface 199 that contacts the extension flange 210 when assembled, as described below. Opposite the first planar surface 199 are a first surface 198 and a second surface 196, the second surface being distal to the first planar surface 199 and the first surface 198 being disposed between the first planar surface 199 and the second surface 196. The second surface 196 comprises a diameter smaller than the diameter of the first surface 198. A through slot 192 having a width w traverses at least half the diameter of the drain plate 190. A second slot 194 at the distal end of the through slot 192 traverses approximately half the thickness t of the drain plate 190. The width w of the through slot 192 is less than the width of the clamp 150 .

[0043] The drain plate 190 may be disposed below the extension flange 210. The clamp 150 includes a hinge 180 opposite the fastener 170. As described above, when the clamp, i.e., the tri-clamp 150, is assembled with the valve, the fastener 170 may be tightened to form a liquid-tight seal, as shown in the valve 612. In practice, the extension flange 210 may first be glued to a bag or container (as shown below) and then assembled to the concave flange as described above. Once the valve 612 is assembled, it may be operated. As shown, the valve 612 is in a closed position. The hinge 180 slides into the second slot 194. At least a portion of the second surface 196 is disposed between the extension flange 210 and the clamp 150. The drain plate 190 may be manufactured from any suitable material, such as metal, ceramic, plastic, and the like. At least one exemplary material is steel, particularly stainless steel. The stainless steel drain plate 190 can be easily cleaned and reused.

[0044] To open the valve 612, the user does not need to grip the clamp 150. In contrast, the user can rotate the first section 26 of the body 14 with one hand. By rotating the body 14 of the valve 612 while non-rotating the clamp 150, the user can open the valve 612 without compromising the seal between the bag and the extension flange 210 and without gripping the clamp 150. Furthermore, due to the interference between the clamp 150, the drain plate 190, and the extension flange 210, the rotational force is not transmitted to the extension flange 210 and therefore there can be no risk of damaging the seal between the bag (not shown) and the extension flange 210.

[0045] Because the fluid transfer device or valve 12, 112, 212, 612, 1112 is preferably provided in a sterile condition (i.e., the interior of the system and any components connected downstream of the valve are pre-sterilized with gamma radiation, ethylene gas, etc. and shipped in a sterile condition), some type of use indicator (not shown) may be useful to inform the user when the system has been used. Alternatively, or in addition to any of the indicator mechanisms described above, a shrink-wrap indicator (not shown) may be placed on the valve, or at least on the rotating first section of the device, to indicate whether the valve has been used.

[0046] The valve 12, 112, 212, 612, 1112 may comprise a plastic material and may be formed by machining the body and plunger assembly and then applying the necessary seals, etc., or in some embodiments by molding the body and plunger separately and assembling them with the seals and other components. Alternatively, the body may be molded in two separate halves, for example a longitudinal half, and assembled by attaching the plunger component with the seals and other components to one half of the body, and then attaching the other half of the body to the plunger, seals, other components, and first half of the body.

[0047] The valve 12, 112, 212, 612, 1112 can be made of metal and / or any plastic material that can withstand steam sterilization. The temperature and pressure of such sterilization is typically about 121° C. and 1 bar above atmospheric pressure. In some cases, more severe conditions such as 142° C. and up to 3 bar above atmospheric pressure may be used. The body and at least the surface of the plunger can withstand these conditions. In some embodiments, the valve 12, 112, 212, 612, 1112 is made of the same material and can withstand these conditions. Suitable materials for this valve include, but are not limited to, PEI (polyetherimide), polyetheretherketone (PEEK), polyetherketone (PEK), polysulfone, polyarylsulfone, polyalkoxysulfone, polyethersulfone, polyphenylene oxide, polyphenylene sulfide, polytetrafluoroethylene (PTFE), and / or mixtures thereof. Alternatively, the surface portion can be made from ceramic or metal inserts alone, or overmolded with a plastic cover. A plasma coating process can also be used to create a polymer surface with a metallic outer layer.

[0048] The above-described embodiments of the present disclosure solve the dead-leg problem of the prior art (see, for example, FIG. 10). FIG. 10 is a prior art system 900 with a bag 100 having a port 908, a tube clamp 906, and a tube 902 (cross section), which creates a dead-leg area. The prior art system 900 is used to mix, sample, and / or deliver a biological fluid 120 containing a processing aid 99, such as an adjuvant, from the bag 100. Fluid 120 from the bag 100 (having a closed volume, not shown) flows in direction A from the closed volume into the tube 902. The tube 902 is connected to the bag 100 via a port 908 having a barb connector 904. The tube 902 is pinched off by a tube clamp 906. In some systems, a disposable valve (not shown) can be placed between the port 908 and the tube 902. The fluid 120 can be dispensed from the system 900 by opening the tube clamp 906. A drawback of this system is that fluid 120 can flow freely through port 908 into tube 902, with region 910 representing a dead-leg region. As shown, dead-leg region 910 has processing aid 99 that has settled from bag 100 or bioreactor into dead-leg region 910. Any portion of tube 902 from top point B to bottom point C represents dead-leg region 910. Any processing aid 99 in dead-leg region 910 can no longer be dissolved in bag 100, i.e., becomes waste. Furthermore, a sample taken from bag 100 through dead-leg region 910 is unlikely to have a concentration representative of the fluid in bag 100. Also, attempts to build a system without dead-leg regions have failed so far. For example, clamp 906 cannot be brought close to bag 100. A sufficient seal cannot be obtained due to the overlap between port 908 and tube 902. Furthermore, damage occurs to port 908 and / or bag 100. If the clamp is lowered so that port 908 and tube 902 do not overlap, a dead leg area will inevitably result.Furthermore, when the clamp 906 is too close to the port 908, the barb connector 904 can move away from the tube 902, creating an area of ​​leakage.

[0049] 11 is a perspective view of an additional embodiment of a valve for use with a bag according to an embodiment of the present disclosure. Some smaller valves, e.g., valves with tubing attached that are less than about 15-30 mm in diameter, may be difficult to operate manually. Some embodiments may be difficult to operate, i.e., open and close, via rotation of parts of the valve. Thus, some embodiments of the present disclosure include valves in which the valve is opened and closed using a push-pull operation.

[0050] 11 is a perspective view of one embodiment of a locking tool 1000 for use with a valve and bag according to an embodiment of the present disclosure. The locking tool 1000 comprises an upper planar surface 1002 and a lower planar surface 1004 with a vertical wall 1014 disposed therebetween. The vertical wall 1014 faces the lower slot 1008 and the upper slot 1006. The vertical wall 1014 forms a small arc connecting the upper planar surface 1002 and the lower planar surface 1004. The upper slot 1006 comprises a slot width W less than or equal to the width of the lower slot 1008. The locking tool 1000 optionally comprises a distal circular region 1012. Two ribs 1010 are formed adjacent the distal circular region 1012. The ribs 1010 can position and releasably lock a valve (shown below) in the upper slot 1006. The radius of the distal circular region 1012 may be substantially equal to the radius of curvature of the valve disposed therein. The locking tool 1000, when a valve connected to a bag as described above is placed therein, allows an operator to actuate the valve, as described more fully below. The locking tool 1000 may be fabricated from any suitable material, such as metal, ceramic, plastic, etc. At least one exemplary material is steel, particularly stainless steel. A stainless steel locking tool 1000 may be easily cleaned and reused. Alternatively, a plastic locking tool 1000 may be easier and less expensive to sterilize and may be selected for disposable use.

[0051] 12 is a front view of a valve 1112 for use with a bag, according to some embodiments of the present disclosure. The valve 1112 can be actuated with a push-pull operation. For example, an operator can hold the conical body section 1028 of the valve 1112 and pull the valve 1112 open or push the valve 1112 closed by grasping the lower section 1060. However, it is not necessary for the operator to hold the body section 1028 while pulling and / or pushing the valve 1112. The operator can simply pull or push the lower section 1060. The locking tool 1000 supports the valve 1112 when pulled or pushed. The lower section 1060 has a bore connected to it and telescopes within the body section 1028. The body section 1028 may have an actuation slot 1058 disposed therein. The upper portion 1030 of the body section 1028 can mate with the locking tool 1000, as shown more fully below. The extension flange 210 further includes a shoulder 140 for mating with the valve 1112. The actuation slot 1058 has a closed end 1058b and an open end 1058a. The pin 1054 is connected to a plunger (not shown) of the valve 1112. The actuation slot 1058 limits linear and axial movement of the plunger from the open end 1058a to the closed end 1058b via the pin 1054. The plunger is connected to a face 90 at the distal end of the plunger, which is disposed within the bore as described above. The plunger may have two or more circumferential seals (not shown), and an opening (not shown) leads to a central plunger bore for fluid transfer. A seal, such as an O-ring 91, surrounds the face 90 and provides a fluid-tight seal with a hole in the extension flange 210 when in the closed position, as shown. When the valve 1112 is opened, the face 90 and O-ring 91 recess through the extension flange 210, providing fluid communication between the plunger and a bag (not shown, but as described above) and the channel or bore through the lower section 1060 and opening 64. Also shown is a barb fitting 92 for accommodating, for example, tubing.A lock 1056 may be disposed in the actuation slot 1058 to prevent inadvertent movement of the pin 1054 from the valve closed position 1058b and the valve open position 1058a, and vice versa.

[0052] 13 is a perspective view of the valve of FIG 12 disposed within the locking tool of FIG 11 for a fluid transfer system according to an embodiment of the present disclosure. The zero dead leg fluid transfer system includes a valve, the valve comprising a conical body section having a lower body section and an upper body section, where an extension flange is joined to the upper body section, a plunger having a central bore disposed within the conical upper body section, the plunger comprising at least one seal adjacent a face, the valve being opened and closed via a pull / push action that allows the plunger to be longitudinally displaced within the conical body section, and a locking tool comprising an upper planar surface and a lower planar surface with a vertical wall disposed therebetween, further comprising a vertical wall opposite the lower slot and the upper slot, the conical body section of the valve being positioned within at least one of the lower slot or the upper slot, and the at least one seal on the plunger forming a fluid tight seal between the plunger and the extension flange.

[0053] A fluid transfer device, e.g., a valve 1112 having a body section 1028 with an elongated bore (not shown), is formed through at least a portion of the lower section 1060, as described above, e.g., a generally hollow movable plunger, i.e., a longitudinally displaceable plunger housed within the elongated bore. The plunger moves axially and linearly relative to the body section 1028. The plunger within the valve 1112 is driven linearly (e.g., axially), thereby operating (i.e., opening and closing) the valve 1112. The surface 90 is retracted within the valve 1112 when in the open position (as shown, the valve is in a closed position). The extension flange 210 is attached to a surface of the bag (not shown in FIG. 13, but substantially as described above), e.g., either the exterior surface of the bag or the interior surface of the bag. An operator can place the locking tool 1000 around the upper portion 1030 of the body section 1028 and pull tightly on the lower portion 1060 of the valve 1112 to open the valve 1112 without tearing the bag. The operator can place one hand under the locking tool 1000 while pulling on the lower portion 1060 with the other hand. However, as noted above, only one hand is needed whether pulling or pushing the lower portion 1060. Similarly, the operator can grip the locking tool 1000 and push on the lower portion 1060 to close the valve 1112 without risking the integrity of the bag. An extension flange 210 is attached to the body section 1028 adjacent the upper portion 1030. The extension flange 210 is attached to the bag and has a hole 1034 extending therethrough so that the face 90 of the plunger and the O-ring 91 on the face 90 can be recessed to be in fluid communication with the hollow plunger and form a liquid tight seal with the hollow plunger. In some embodiments, a tube is attached to the barb fitting 92, such as a tube having an inside diameter of 10-25 mm or less.

[0054] The embodiments according to the present disclosure also include a method for processing a biological fluid. For example, the biological fluid(s) can be delivered or otherwise provided in a bag or bioreactor having an internal volume. A fluid transfer device, such as a valve, is in downstream fluid communication with the bag or bioreactor. Typically, downstream components, such as a valve, are located at or near the bottom of the bag or bioreactor. The fluid transfer device is attached to the bag or bioreactor along an extended area of ​​a flange or integral part of the fluid transfer device attached to the fluid transfer device. The biological fluid is mixed. A typical means for mixing the biological fluid comprises an impeller and / or mixing blades. The impeller may be attached to a physical shaft as a drive mechanism. Alternatively, the impeller may be powered by a magnetic drive pump using a balanced magnetic field to generate rotation of the impeller. During rotation, the rotating magnetic field affects the internal impeller magnet. When the two magnets start to rotate together, the impeller starts to rotate, thus displacing the fluid. Additionally, a solid processing agent can be delivered to the internal volume. The solid processing agent is mixed with the biological fluid. In some embodiments, the fluid transfer device comprises a flange. The flange may comprise a relatively large surface for attachment to the bag or bioreactor. The fluid transfer device may also comprise a plunger for providing a fluid-tight seal when in the closed position and for allowing delivery of the fluid when in the open position. In some embodiments, the flange comprises a top surface that is substantially flush with the surface of the plunger during the closed position. In some embodiments, the surface of the plunger is higher than the top surface of the flange. Because the flange is glued to the bag or bioreactor, mixing occurs without dead-leg areas, greatly improving mixing efficiency. In addition, for example, if a sample is required during processing of the fluid, the sample will also be more representative of the concentration of various drugs and auxiliary agents. For example, one drug that is difficult to mix is ​​aluminum salts, which are typically used as adjuvants. In some embodiments, the method includes a biological fluid for culturing, such as a monoclonal antibody.

[0055] According to certain embodiments, the bag, bioreactor, or disposable container is designed to receive and retain a fluid. In some embodiments, the bag, bioreactor, or disposable container comprises a single or multi-layer flexible wall formed of a polymer composition such as polyethylene, including ultra-high molecular weight polyethylene (UHMWPE), very low density polyethylene (ULDPE), linear low density polyethylene (LLDPE), low density polyethylene (LDPE), medium density polyethylene (MDPE), polypropylene (PP), ethylene vinyl alcohol (EVOH), polyvinyl chloride (PVC), polyvinyl acetate (PVA), ethylene vinyl acetate copolymer (EVA copolymer), thermoplastic elastomer (TPE), and / or blends or alloys of any of the aforementioned materials, as well as various other thermoplastic materials and additives known to those skilled in the art. The disposable container may be formed by various processes, including, but not limited to, coextrusion of similar or different thermoplastic resins, multi-layer laminates of different thermoplastics, welding and / or heat treatment, heat staking, calendaring, etc. Any of the aforementioned processes may further comprise layers such as adhesives, tie layers, primers, surface treatments, etc., to promote adhesion between adjacent layers. By "different" it is meant that different polymer types, such as a polyethylene layer with one or more layers of EVOH, as well as the same polymer type but with different properties such as molecular weight, linear or branched polymer, fillers, etc., are contemplated herein. Typically, medical grade plastics, and in some embodiments, plastics that do not contain animal material, are used to manufacture the container. Medical grade plastics can be sterilized, for example, by steam, ethylene oxide, or radiation, including beta and / or gamma radiation. Also, most medical grade plastics are specified for low gas transfer with good tensile strength. In some embodiments, medical grade plastics include polymeric materials that are transparent or translucent, allowing visual monitoring of the contents, and are typically weldable and non-supporting. In some aspects, the container can be a bioreactor capable of supporting a biologically active environment, such as a bioreactor capable of growing cells in a cell culture setting.In some embodiments, the bag, bioreactor or container may be a two-dimensional (2D) or "pillow" bag, or alternatively, the container may be a three-dimensional (3D) bag. The particular geometry of the container or bioreactor is not limited in any of the embodiments disclosed herein. In some embodiments, the container may include a rigid base that provides an access point such as a port or vent. Any container described herein may include one or more inlets, one or more outlets, and optionally other features such as sterile gas vents, spargers, and ports for sensing the liquid within the container for parameters known to those skilled in the art such as conductivity, pH, temperature, dissolved gases, e.g., oxygen and carbon dioxide. The container is of sufficient size to accommodate the cells and fluids such as culture media to be mixed from benchtop scale to, e.g., 3000 L or larger bioreactors.

[0056] The inner wall of the plastic film may be specified to heat seal with a flange of a fluid transfer device, such as a valve. Similarly, if a specific plastic film is indicated, the flange, generally comprising a polymeric material, may be specified to heat seal with the specific plastic film. In some embodiments, ultrasonic welding, RF welding, contact heating, induction heating, and other heating methods known to those skilled in the art may be used to create a bond between the flange and the plastic film. In some embodiments, a primer may be used between the plastic film and the flange. In some embodiments, an adhesive bonding layer is used to bond the plastic film and the flange. The flange may be of any suitable thickness. In some embodiments, the thickness of the flange is a function of the desired stiffness. For example, a flange comprising a polypropylene polymeric material may be about, for example, 1.0 to 3.0 millimeters thick. In some embodiments of the present disclosure, the flange may include a surface treatment, such as ozone treatment, to enhance the bond with the plastic film. In some embodiments, the flange is stable to steam and / or gamma radiation for sterilization purposes. In some embodiments, the diameter of the flange may be specified for a specific application. For example, in applications requiring large amounts of difficult to dissolve processing aids, users may need to use larger flanges so that initially undissolved material remains in the area of ​​the bioreactor where mixing is most efficient. In some embodiments, the flanges can be used as a means to position / orient the device. See, for example, U.S. Patent Nos. 9,187,240, 9,272,840, and 9,090,398, filed by EMD Millipore Corporation, the art of which is incorporated by reference in its entirety.

[0057] Some embodiments of valves according to the present disclosure can be found, for example, in U.S. Pat. Nos. 8,690,120 and 10,247,312, filed by EMD Millipore Corporation, each of which is incorporated by reference in its entirety.

[0058] In some embodiments, the bag, bioreactor, or container may be a disposable, deformable, collapsible bag that defines a closed volume, is sterilizable for single use, is capable of containing contents, such as a biopharmaceutical fluid, in a fluid state, and is capable of containing a mixing device partially or completely within the closed volume of the container, e.g., within a working volume. In some embodiments, the closed volume can be opened, such as by a suitable valve, to introduce fluid into the volume and to withdraw fluid therefrom, such as after mixing is completed.

[0059] In some embodiments, each container partially or completely houses therein an impeller assembly for mixing, dispersing, homogenizing, and / or circulating one or more liquids, gases, and / or solids contained in the container. The impeller assembly can include one or more blades that are movable, such as by rotation or oscillation about an axis. The impeller assembly converts the rotational motion into a force that mixes the fluids that it contacts. The impeller assembly can be formed at the top of the container and extend downwardly into the container volume via a shaft. The shaft is connected to a motor outside the container, the shaft having one or more impeller blades thereon. Such assemblies are often referred to as "lightning style" assemblies. Also, in some embodiments, the impeller assembly can be formed at the bottom of the container and connected to the motor by a direct shaft to the motor outside the container, or alternatively, magnetically coupled to the motor so that the shaft does not need to penetrate the wall of the container.

[0060] All ranges in the formulas recited herein include the ranges therebetween and may include or exclude the endpoints. Optionally included ranges are from integer values ​​therebetween (or including one original endpoint), in the order of magnitude recited or the next smaller order of magnitude. For example, if the lower range value is 0.2, the optional included endpoints can be 0.3, 0.4, etc. If the larger range is 8, such as 1.1, 1.2, etc., as well as 1, 2, 3, etc., the optional included endpoints can be 7, 6, etc., as well as 7.9, 7.8, etc. One-sided ranges such as 3 or more also include consistent ranges (or ranges) starting from the order of magnitude recited or the next lower integer value. For example, 3 or more includes 4 or 3.1 or more.

[0061] Throughout this specification, reference to "one embodiment," "a particular embodiment," "one or more embodiments," "some embodiments," or "embodiments" indicates that a feature, structure, material, or characteristic described in connection with an embodiment is included in at least one embodiment of the present disclosure. Thus, appearances of phrases such as "in one or more embodiments," "a particular embodiment," "in one embodiment," "some embodiments," or "in an embodiment" throughout this specification are not necessarily referring to the same embodiments.

[0062] Although some embodiments have been described above, other implementations and applications are within the scope of the following claims. Although the present specification has been described with reference to certain embodiments, it should be understood that these embodiments are merely illustrative of the principles and applications of the present disclosure. It should be further understood, therefore, that numerous modifications can be made to the exemplary embodiments, and that other arrangements and patterns can be devised without departing from the spirit and scope of the embodiments according to the present disclosure. Furthermore, the particular features, structures, materials, or characteristics can be combined in any suitable manner in any one or more of the embodiments.

[0063] The patent applications and patents and other non-patent publications cited in this specification are hereby incorporated by reference in their entirety, at the entirety of the portion cited, as if each individual publication or reference was specifically and individually indicated to be incorporated by reference herein as if fully set forth. Any patent application to which this application claims priority is also incorporated by reference herein in the manner described above for publications and references.

Claims

1. A valve, a body having a first section and a second section; an elongated bore extending through the body and having a proximal end and a distal end; a longitudinally displaceable plunger disposed within the bore and extending along the bore, the plunger having a proximal end and a distal end, the plunger having a first position displaced toward the distal end of the bore and a second position displaced toward the proximal end of the bore, the plunger further comprising an upper surface; a diaphragm seal attached to the proximal end of the plunger and sealing the bore at said proximal end; a gland seal sealing the bore at a location intermediate the diaphragm seal and the distal end of the bore; a flange attached to or disposed as an integral part of the second section of the body, the flange having an upper surface that is substantially flush with an upper surface of the plunger or the upper surface of the plunger is higher than an upper surface of the flange; a fluid transfer opening in the bore between the diaphragm seal and the gland seal; Equipped with The plunger penetrates the gland seal and is sealingly secured to the gland seal. Longitudinal displacement of the plunger moves the diaphragm seal to open the bore, the gland seal responds to displacement of the plunger and stretches to maintain a seal around the plunger, a fluid flow path is established between the open proximal end of the bore and the fluid transfer opening, and longitudinal displacement of the plunger toward its first position moves the diaphragm to open the bore; valve.

2. 2. The valve of claim 1, wherein a surface of the flange is substantially flush with a surface in the second position when the plunger is displaced toward the proximal end of the bore, forming a zero dead leg position.

3. 3. A valve as claimed in claim 1 or 2, wherein a portion of the bore between the diaphragm seal and the gland seal is substantially sterile.

4. 4. The valve of claim 3, further comprising a substantially sterile connection component for attaching the valve to an upstream component.

5. A valve as claimed in any preceding claim, wherein the diaphragm seal is located at least partially inside the proximal end of the bore prior to displacement of the plunger.

6. A valve according to any one of claims 1 to 5, wherein the gland seal and / or the diaphragm seal are constructed of a silicone elastomer or a solvent resistant fluoroelastomer.

7. A valve as claimed in any one of the preceding claims, wherein the body comprises a substantially cylindrical outer portion, at least one alignment slot for the plunger and a groove for the gland seal.

8. A valve as claimed in any preceding claim, wherein the flange further comprises a boss extending into the elongated bore.

9. A valve according to any one of claims 1 to 8, wherein the flange is capable of forming a joint with a flexible bioreactor bag.

10. 10. The valve of claim 9, wherein the flange forms a heat-sealed or adhesive bond with the flexible bioreactor bag.

11. A fluid transfer kit, the fluid transfer kit comprising a valve, The valve is a body having a first section and a second section; an elongated bore extending through the body and having a proximal end and a distal end; a longitudinally displaced plunger disposed within and extending along the bore, the plunger having a proximal end and a distal end, the plunger having a first position displaced toward the distal end of the bore and a second position displaced toward the proximal end of the bore; a diaphragm seal attached to the proximal end of the plunger and sealing the bore at said proximal end; a gland seal sealing the bore at a location intermediate the diaphragm seal and the distal end of the bore; a flange attached to or disposed as an integral part of the second section of the body; a flexible bag attached to a flange, the flange being substantially flat and including an extension area that can be attached to the flexible bag; Equipped with Longitudinal displacement of the plunger moves the diaphragm seal to open the bore, the gland seal responds to the displacement of the plunger and stretches to maintain a seal around the plunger, a fluid flow path is established between the open proximal end of the bore and the fluid transfer opening, and as the plunger is displaced toward the proximal end of the bore, a surface of the flange is substantially flush with a surface of the plunger, creating a zero dead leg position. kit.

12. 12. The kit of claim 11, wherein the valve, a connection component for attaching the valve to an upstream component, at least one length of flexible tubing, and at least one sample container are connected and substantially sterile.

13. A valve, comprising: The main body, an elongated bore extending through the body and having a proximal end and a distal end; a longitudinally displaceable plunger disposed within and extending along the bore, the plunger having a proximal end and a distal end, the plunger having a first position displaced toward the distal end of the bore and a second position displaced toward the proximal end of the bore; at least one seal attached to the plunger to form a fluid-tight seal between the plunger and the bore; a fluid transfer opening in the plunger between the proximal end of the plunger and the distal end of the plunger; Equipped with Longitudinal displacement of the plunger opens the bore to form a fluid path from the upstream component to the downstream component through the fluid transfer opening and the channel in the plunger. valve.

14. 14. The valve of claim 13, wherein at least one seal is a diaphragm seal.

15. 15. A valve as claimed in claim 13 or 14, wherein a diaphragm seal is attached to the proximal end of the plunger and seals the bore at said proximal end.

16. A valve according to any one of claims 13 to 15, wherein at least one seal is a gland seal.

17. 16. The valve of claim 15, wherein the valve further comprises at least one gland seal.

18. 18. The valve of claim 17, wherein the gland seal seals the bore at a location intermediate the diaphragm seal and a distal end of the bore.

19. 20. The valve of claim 17, wherein the plunger penetrates and is sealingly secured to the at least one gland seal.

20. 20. The valve of claim 17, wherein the at least one gland seal expands in response to displacement of the plunger to maintain a seal around the plunger.

21. 16. The valve of claim 15, wherein longitudinal displacement of the plunger toward the first position moves the diaphragm to open the bore.

22. 20. The valve of claim 19, wherein a portion of the bore between the diaphragm seal and the at least one gland seal is substantially sterile.

23. 23. The valve of claim 22, further comprising a substantially sterile tank mount.

24. 16. The valve of claim 15, wherein the diaphragm seal is disposed at least partially inside the proximal end of the bore prior to displacement of the plunger.

25. A valve according to any one of claims 13 to 24, wherein at least one seal is constructed from a silicone elastomer.

26. The valve of any one of claims 13 to 25, wherein at least one seal is constructed from a solvent resistant fluoroelastomer.

27. 18. The valve of claim 17, wherein the body comprises a substantially cylindrical outer portion, at least one alignment slot for the plunger, and a groove for the gland seal.

28. 1. A method for treating a biological fluid, comprising: Providing a biological fluid in a bag or bioreactor having an interior volume; providing a valve in downstream fluid communication with the bag or bioreactor, the valve being attached to the bag or bioreactor along an extension region of a flange; Providing a means for mixing the biological fluid; delivering a solid processing agent to the interior volume; mixing a solid processing agent with a biological fluid, the mixing being performed without a dead-leg region; A method for providing the above.

29. 30. The method of claim 28, wherein a top surface of the plunger of the valve is flush with a surface of the flange.

30. 29. The method of claim 28, wherein the valve is a valve according to claim 1.

31. 30. The method of claim 28, wherein the means for mixing comprises an impeller.

32. The method of claim 31 , wherein the impeller is a magnetically driven impeller.

33. 29. The method of claim 28, wherein the solid processing agent is an aluminum salt.

34. 30. The method of claim 28, further comprising the step of obtaining a sample of the biological fluid from within the interior volume of the bag or bioreactor via the valve.

35. 30. The method of claim 28, wherein the biological fluid comprises a monoclonal antibody.

36. 30. The method of claim 28, further comprising the step of rendering the valve sterile.

37. 1. A zero dead-leg fluid transfer system, comprising: A valve, a conical body section having a lower body section and an upper body section, the extension flange being joined to the upper body section; a plunger having a central bore disposed within a conical upper body section, the plunger including at least one seal adjacent a face, the valve being opened and closed via a pull / push action that allows the plunger to be longitudinally displaced within the conical body section; a valve comprising: a locking tool comprising an upper planar surface and a lower planar surface having a vertical wall disposed therebetween, the locking tool further comprising vertical walls opposing the lower slot and the upper slot, the conical body section of the valve being positioned within at least one of the lower slot or the upper slot; A zero dead leg fluid transfer system, wherein at least one seal on the plunger forms a fluid tight seal between the plunger and the extension flange.

38. 40. The fluid transfer system of claim 37, wherein at least one seal is a diaphragm seal.

39. 39. The fluid transfer system of claim 37 or 38, wherein the diaphragm seal is attached to the proximal end of the plunger and seals the bore at said proximal end.

40. The fluid transfer system of any one of claims 37 to 39, wherein at least one seal is constructed of a silicone elastomer or a solvent resistant fluoroelastomer.

41. The fluid transfer system of any one of claims 37 to 40, wherein an extended flange is attached to the bag.

42. The fluid transfer system of any one of claims 37 to 41, wherein the plunger comprises a pin.

43. 43. The fluid transfer system of claim 42, wherein the body section includes an operating slot for receiving a pin, the pin limiting movement of the plunger.

Citation Information

Patent Citations

  • Disposable sterile fluid transfer device

    JP2005519825A

  • Fluid transfer device

    JP2009120402A

  • Disposable valves and flexible containers for pressurized bioreactors

    JP2015512017A

  • Drain valve with rotatable angled outlet

    JP2018204789A